Resources Contact Us Home
Recombinant vaccine for diseases caused by encapsulated organisms

Image Number 5 for United States Patent #6326001.

Vaccines for diseases caused by normally encapsulated organisms are produced by genetically modifying those organisms by deleting the genes encoding for capsule synthesis or a portion thereof sufficient to produce non-capsulated mutants of the organisms. As an example, a live, attenuated strain of Actinobacillus pleuropneumoniae genetically modified with a large deletion in a chromosomal regions of the DNA which encodes for capsule synthesis is a safe and effective vaccine against swine pleuropneumonia.

  Recently Added Patents
Host route convergence based on sequence values
Defect inspection method and device therefor
Resist underlayer film forming composition for lithography, containing aromatic fused ring-containing resin
Automated processing machine used for processing samples placed on slides and having an output device
Hydrothermal synthesis of nanocubes of sillenite type compounds for photovoltaic applications and solar energy conversion of carbon dioxide to fuels
High gradient lens for charged particle beam
One-dimensional metal nanostructures
  Randomly Featured Patents
Methods for treating eye conditions
Porous particles for deep lung delivery
Preparation that contains oligosaccharides and probiotics
Measurement system and method for monitoring the measurement system
Printer having transport device for correcting image distortion
Recording medium containing supplementary service information for audio/video contents, and method and apparatus of providing supplementary service information of the recording medium
Segmented box-in-box for improving back end overlay measurement
Bridge type punch press
Material processing apparatus
System and method for reducing memory requirements for electrical domain compensation of intra-channel nonlinearity in an optical communications system